<DOC>
	<DOCNO>NCT00957996</DOCNO>
	<brief_summary>This Phase 3 , open-label , randomize study antiviral activity , safety , tolerability intravenous Peramivir hospitalize subject confirm suspected influenza infection .</brief_summary>
	<brief_title>Safety Study IV Peramivir Hospitalized Subjects With Confirmed Suspected Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Peramivir</mesh_term>
	<criteria>Male nonpregnant female subject 6 year age old . Able provide write informed consent , write consent may provide parent guardian legally authorize representative , unless consent provide parent , guardian legally authorize representative consistent applicable local ethical procedure , directive /or guideline . Presence clinical sign and/or symptom consistent acute illness compatible influenza infection ; measure temperature ≥ 38.0°C ( 100.4°F ) oral , ≥ 38.6°C ( 101.4°F ) rectal tympanic recent onset least one following : rhinorrhea nasal congestion , sore throat cough . Measured temperature include fever meeting criterion report subject parent , guardian legally authorize representative 24 hour prior Screening . The requirement fever waive subject influenza infection already confirm laboratory test ( include Rapid Antigen Tests ) . Confirmation influenza A B infection local community one following mean : institution 's local laboratory , local public health system national public health system laboratory recognize national multinational influenza surveillance scheme . Severity illness requiring anticipate require inhospital care . Subjects hospitalize great 24 hour ( include time spent emergency department ) .Blood platelet count &lt; 20 x 109/L . Serum bilirubin &gt; 6 mg/dL time Screening evaluation . Serum ALT AST &gt; 5 X upper limit normal time Screening evaluation . Serum creatinine &gt; 5.0 mg/dL time Screening evaluation . Subjects require peritoneal dialysis hemofiltration . Altered neurologic status define Glasgow Coma Score ≤ 9 , unless medically induce . Females pregnant ( positive urine serum pregnancy test Screening evaluation ) breastfeeding . Actively undergoing systemic chemotherapy radiotherapy treatment malignancy . ( Subjects complete treatment 30 day prior enrollment allow enroll study . Hormone treatment cancer also acceptable ) . Prior hematopoietic stem cell transplantation solid organ transplant previous 4 month . HIV infection know CD4 count &lt; 200 cells/ mm3 unless stable highly active antiretroviral ( HAART ) regimen least 6 month . Presence preexist chronic infection undergo require medical therapy ( eg , tuberculosis ) . ( Subjects chronic osteomyelitis hepatitis B C require treatment exclude ) . Presence preexist illness , opinion Investigator , would place subject unreasonably increase risk participation study . Participation subject study experimental treatment condition within 30 day prior time Screening evaluation . Subjects diagnose cystic fibrosis . Subjects confirm clinical evidence acute noninfluenzal infection time Screening .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>influenza</keyword>
	<keyword>hospitalize</keyword>
	<keyword>flu</keyword>
	<keyword>antiviral</keyword>
</DOC>